Anaplastic lymphoma kinase (ALK) gene alteration in gastric signet ring cell carcinoma.

about

Anaplastic lymphoma kinase (ALK) gene alteration in gastric signet ring cell carcinoma.

Item

http://www.wikidata.org/entity/Q53692985

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Anaplastic lymphoma kinase (ALK) gene alteration in gastric signet ring cell carcinoma.

@en

type

Item

label

Anaplastic lymphoma kinase (ALK) gene alteration in gastric signet ring cell carcinoma.

@en

prefLabel

Anaplastic lymphoma kinase (ALK) gene alteration in gastric signet ring cell carcinoma.

@en

P1476

Anaplastic lymphoma kinase (ALK) gene alteration in gastric signet ring cell carcinoma.

@en

P2093

Hong Zong

http://www.w3.org/2001/XMLSchema#string

Lijie Song

http://www.w3.org/2001/XMLSchema#string

Ruihua Zhao

http://www.w3.org/2001/XMLSchema#string

Wei Cao

http://www.w3.org/2001/XMLSchema#string

Weijie Zhang

http://www.w3.org/2001/XMLSchema#string

Wenjing Jiang

http://www.w3.org/2001/XMLSchema#string

Xiangke Li

http://www.w3.org/2001/XMLSchema#string

Xinguang Cao

http://www.w3.org/2001/XMLSchema#string

Zhiwei Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Treating patients with ALK-positive non-small cell lung cancer: latest evidence and management strategy

Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

Cancer statistics, 2014

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum

P304

569-574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/CBM-160599

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27002760

http://www.w3.org/2001/XMLSchema#string